Viewing Study NCT01134432


Ignite Creation Date: 2025-12-24 @ 9:34 PM
Ignite Modification Date: 2026-02-01 @ 4:53 PM
Study NCT ID: NCT01134432
Status: COMPLETED
Last Update Posted: 2013-09-10
First Post: 2010-05-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Prednisolone +/- Addition of Anti-CD20 Antibody, Rituximab, in Patients With Immune Hemolytic Anemia
Sponsor: Copenhagen University Hospital at Herlev
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anemia, Hemolytic, Autoimmune View
Keywords:

Keywords

Keyword Brief Keyword Text View
None autoimmune hemolytic anemia View
None hemolytic anemia View
None Rituximab View
None Treatment of autoimmune hemolytic anemia View
None warm antibody dependant autoimmune hemolytic anemia View